Part B Drugs At Home: Medicare Policy Responds To COVID-Driven Access Concerns

 
• By Cathy Kelly

Temporary policy may open door to longer term change as Medicare allows reimbursement of at-home administration of non-hospital drugs covered by Part B under a recently-released regulation aiding at encouraging telehealth during the coronavirus outbreak.

Intravenous drip
Instead of an intravenous drip, policy change in the coronavirus era has felt more like a bolus.

More from Market Access

More from Pink Sheet